Advertisement Eisai to launch new motion sickness drug - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Eisai to launch new motion sickness drug

Eisai has announced that it will launch a new motion sickness remedy 'Travelmin churop grape flavor' on February 16, 2009. The product is believed to be the first OTC motion sickness remedy in drop type.

Eisai has said that the Travelmin churop grape flavor prevents and alleviates symptoms of motion sickness such as dizziness and nausea with antihistaminic component (d-chlorpheniramine maleate) and anticholinergic component (scopolamine hydrobromide hydrate). It can be taken by adults as well as children five years and older.

Since the introduction of the original ‘Travelmin’, Eisai has been marketing various motion sickness remedies including ‘Travelmin Junior’, ‘Travelmin Family’, ‘Travelmin R’ and ‘Travelmin Liquid’.